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Abstract
Objective: The relationship between weight loss and mortality has important clinical and public health significance but has
proved to be complex. Evidence is mixed and particularly limited on the association between weight loss in mid-life and
premature death (i.e. before 65 years of age), a small albeit important segment of total mortality. We aimed to study the
association between midlife weight change and mortality accounting for health and lifestyle characteristics, and also
considering potential bias due to preexisting chronic diseases and smoking status.
Design: Longitudinal, population-based, ‘the 1946 British’ birth cohort study.
Subjects and Measures: In 2750 men and women, mortality from age 53 through 65 years was analyzed according to
categories of measured 10 year weight change between 43 and 53 years. Cox’s hazard ratios (HR) were progressively
adjusted for socio-demographic, lifestyle and health characteristics.
Results: Nearly 20% of participants lost weight and over 50% gained 5 kg or more in midlife. There were 164 deaths.
Compared to those who gained between 2 and 5 kg, those who lost 5 kg or more had an increased risk of premature death
independently of midlife physical activity, socio-economic circumstances and educational attainment. This association was
unaltered when highest weight loss (lost more than 15 Kg) (p = 0.04) and early deaths were excluded (p,0.001), but was no
longer significant after adjustment for cardiovascular risk factors and health status (HR= 1.8; 95% CI: 0.9 to 3.5).
Conclusion: The inverse association between weight loss in midlife and higher risk of premature death may be explained by
vascular risk factors and ill health. In consideration of the burden of premature death, closer monitoring of weight loss in
mid-life is warranted.
Citation: Albanese E, Strand BH, Guralnik JM, Patel KV, Kuh D, et al. (2014) Weight Loss and Premature Death: The 1946 British Birth Cohort Study. PLoS ONE 9(1):
e86282. doi:10.1371/journal.pone.0086282
Editor: Jennifer Beam Dowd, Hunter College, City University of New York (CUNY), CUNY School of Public Health, United States of America
Received June 6, 2013; Accepted December 11, 2013; Published January 21, 2014
Copyright:  2014 Albanese et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The NSHD study is funded by the MRC Unit for Lifelong Health and Ageing, UK and was supported in part by the Intramural Research Program of the
National Institute on Aging, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation
of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: emiliano.albanese@gmail.com
Introduction
Premature death (i.e. before 65 years of age) is a small segment
of total mortality but of great clinical and public health importance
[1]. Underweight as well as overweight and obesity are associated
with an increased mortality risk in midlife populations [2].
However, higher weight and higher body mass index (BMI) seem
to become protective in terms of mortality with increasing age
[3,4]. Although weight loss at older ages has been related with
increased mortality rates in some studies, [5–8] overall evidence is
conflicting [9–11] and the reasons underlying any such association
remain unclear. The contradictory findings to date may be, at least
in part, ascribed to the fallacies of observational studies, [12] and
the observation that at older ages overweight may be protective
with respect to some chronic diseases [13]. A number of challenges
when addressing the association between weight loss and mortality
have been identified which must be dealt with appropriately in
analyses. First, smoking is a strong risk factor for mortality but
smokers also tend to have a lower body weight than non-smokers.
Second, potentially mediating vascular risk factors may improve
with weight loss. Finally, there is the possibility that health status
and clinical conditions which lead to mortality also cause weight
loss either through the clinical disease process or by prompting
attempts to lose weight after a condition is diagnosed [14]. Weight
loss is also a marker of disease severity, [15] and may aggravate the
vital prognosis of several diseases [16]. The association of weight
change with mortality has not yet been studied addressing
comprehensively these challenges that might bias the findings,
[17] and there is a lack of evidence on the association between
weight loss in midlife, as opposed to weight loss in older age, and
premature death.
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We used data from a British birth cohort study to test the
hypothesis that weight loss over a 10-year period in midlife (43–
53 years) would be associated with an increased risk of all-cause
premature death between 53 and 65 years. We also investigated
whether health conditions (including cancer history, as well as
cardiovascular diseases and risk factors), smoking, and body size at
age 43 explained any observed associations.
Materials and Methods
Ethics statement
Participants provided written informed consent and the Multi-
centre Research Ethics Committee (MREC) approved the study.
Data Availability
Bona fide researchers can apply to access the NSHD data via a
standard application procedure (see details at: http://www.nshd.
mrc.ac.uk/data.aspx).
Study population and follow-up
The MRC National Survey of Health and Development
(NSHD) is an ongoing birth cohort study of a socially-stratified
sample of 5 362 newborns born in England, Scotland and Wales in
one week in March 1946, and followed up 24 times. Height and
weight were measured at all study waves to the nearest 0.1 kg with
participants in light clothing and no shoes (self-reported at 20 and
26 years). In 1989 and 1999 trained nurses used standardized
protocols at home visits to assess health and lifestyle characteristics.
Cohort members were flagged for death on the National Health
Service (NHS) Central Register. The start of mortality follow-up
was taken as 1999 when cohort members were aged 53 years and
ended in March 2011, just before the study members’ 65th
birthday. Of the 5 362 cohort members 469 had died before age
53 years, 640 had withdrawn from the study, 580 lived abroad,
and 638 were untraced or non-responders. Of the remaining 3
035, we excluded those who were not weighed and measured at
both 43 and 53 years (n = 274) and those who did not have
mortality data available (n = 11) leaving 2 750 for analysis. A
further 182 were excluded from complete-case analyses due to
missing covariate information.
Exposure and covariates assessment
The exposure variable was 10 year weight change calculated by
subtracting weight at age 43 from weight at age 53 years. We
derived a categorized variable for weight change using the
following groups: [5] 1) 25 kg or more; 2) –4.99 to–2 kg; 3)
21.99 to +2 kg; 4) +2 to +5 kg; 5) 5.01 kg or more.
We classified educational attainment achieved by the age of
26 years according to the Burnham scale into: [18] 1) higher
education/postsecondary college or university degree, 2) advanced
secondary education/university entrance qualification, 3) ordinary
secondary education/junior high school qualifications, 4) below
ordinary secondary qualification, and 5) no qualification. Other
covariates were included consistent with previous findings from the
NSHD. Household occupational social class at age 53 years
according to the Registrar General system: 1) I professional and II
intermediate, 2) III non-manual skilled, 3) III manual skilled, 4) IV
partly skilled and V unskilled; [19] smoking habit at 43 and
53 years: 1) no smokers at both ages, 2) smokers at 43 or at
53 years, 3) smokers at both ages. Additional potential confound-
ers related to health status included: [10] physical activity level at
43 and 53 years (defined as any sports, exercises or vigorous leisure
activities taken in the month preceding the: none, 1–4 times a
month or more than 4 times a month); Rose angina Grade I or II
elicited by standardized questions; self-reported stroke; diagnosed
or undiagnosed hypertension at 43 years (those on antihyperten-
sive treatment and/or with measured systolic blood pressure
.=160 and diastolic .=100); lung function at 43 years (forced
expiratory volume (FEV1) measured using the Micromedical
turbine electronic spirometer). These covariates capture partici-
pants’ morbidity status and are also potentially associated with
dieting and changes and/or restrictions in physical activity level
and are therefore best measured at the beginning of the weight
change period. Health characteristics at start of mortality follow-
up were determined in 1999 (at 53 years) by eliciting information
about history of type II diabetes, cancer, liver disease and thyroid
disorder between 43 and 53 years and by recording any recent
(past 3 weeks) abdominal or chest surgery and finally by asking the
question: ‘have you recently felt that you are ill?’ (y/n) to measure
self-rated health at 53 years. This latter set of health characteristics
likely impacts both the 10 year weight change period and the
follow-up period.
Statistical analysis
We compared participants’ characteristics across weight change
categories using ANOVA and x2. A priori power calculations (at
90% and 5% significance) confirmed that a hazard ratio (HR) of
1.03 per kg of weight change could be detected assuming a linear
relationship. Weight change predicted mortality similarly in men
and women (P-value for sex interaction = 0.93), so results are
presented for men and women together adjusted for sex.
Survival across weight change categories was first assessed by
graphical inspection of Kaplan-Meier plot, and a formal test using
Schoenfeld residuals showed no violation of the proportionality
assumption (P= 0.41). To assess the relationship between weight
change and mortality we performed two separate analyses. First,
we included weight change as a continuous variable and used
restricted cubic spline with three knots to assess the shape of the
association with mortality rates. The association with mortality
was assessed using the Cox proportional hazards model adjusting
for sex and weight at 43 years. The p-value for overall significance
of the association was obtained comparing the spline models with
the null model using a Wald test (N=2 750, deaths = 164).
Second, the relationship between weight change and mortality was
modeled using the Cox model with weight change in categories
(above), initially on the maximum sample with weight change
available (n = 2 750, deaths = 144). The unadjusted model was
then refitted on a reduced sample with complete data on all
covariates (n = 2 568) to assess potential bias introduced by missing
data. Adjustment was then made for socio-demographic, lifestyle
and health characteristics in stages to assess confounding. To
account for the possibility that existing underlying disease, which
results in mortality, may have caused the weight loss, [17] we
carried out sensitivity analyses excluding individuals with highest
weight loss (15 Kg or more; n = 20), and, separately, deaths that
occurred in the first 2 years of follow-up. We then included
interaction terms of weight change by obesity (BMI .30 Kg/m2)
at 43 years, and by smoking status (yes/no) at the beginning of the
weight loss period (43 years) to formally test whether obesity and
smoking status modified the association of weight change with
mortality. We also conducted separate analyses by subgroup where
evidence of an interaction was observed. Finally, because weight
change is likely related to body size, in additional models we
investigated the relationship between BMI (in categories; under-
weight: BMI,18.5, normal weight: 18.5, BMI,25, overweight:
25, BMI ,30, and obesity: BMI $30 Kg/m2) at 43 years and
mortality controlling for sex, and weight change. A similar model
was fitted replacing BMI at 43 years with BMI at 53 years. We
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Table 1. Characteristics of the analytic sample (n = 2568) by categories of 10-years weight change, the 1946 British birth cohort
study.
Weight change between 43 and 53y
25 Kg or
more
24.9 to
22 kg
22.1 to
2 Kg
2.1 to
5 Kg
5.1 Kg or
more
Sample size 125 (4.9) 168 (6.5) 500 (19.5) 540 (21.1) 1235 (48.1)
Sex, % 0.007
Women 48.0 47.1 48.2 46.9 54.8
Men 52.0 52.9 51.8 53.1 45.2
Education, % 0.115
Higher 5.6 9.5 10.0 11.3 9.15
Advanced secondary 17.6 17.3 24.0 27.8 25.8
Ordinary secondary 30.4 22.1 24.4 21.7 24.2
Vocational 42.4 44.6 37.2 34.6 36.0
No qualification 4.0 6.6 4.4 4.6 4.8
SEP, % ,0.001
I & II 28.0 31.5 43.8 48.5 43.9
III non-manual 20.8 19.1 21.0 21.3 25.5
III manual 29.6 22.6 18.8 18.3 15.1
IV & V 21.6 26.8 16.4 11.8 15.6
Smoking habit, % ,0.001
No smoker 55.2 63.1 68.4 74.6 69.0
Smoke once (either 43 or 53y) 12.0 7.1 8.0 7.4 14.2
Smoker 32.8 29.7 23.6 18.0 16.8
Physical act. level at 43y, % 0.003
None 67.2 51.2 50.8 44.6 51.9
1–4 times a month 9.6 13.1 15.2 17.0 15.2
4+ times a month 23.2 35.2 34.0 38.0 32.8
Physical act. level at 53y, % 0.024
None 60.0 52.4 46.8 44.7 49.4
1–4 times a month 10.4 17.7 16.6 18.3 18.8
4+ times a month 29.6 30.4 36.6 37.4 31.7
Health at 43years, %
Angina 0.8 3.0 1.2 1.9 1.5 0.482
Stroke 1.6 0.6 0.2 0.2 0.2 0.102
Hypertension 10.4 6.0 7.2 5.4 5.5 0.172
Lung function FEV1, mean (sd) 2.85 (0.8) 2.89 (0.7) 3.00 (0.7) 3.05 (0.7) 3.02 (0.7) 0.014
Health at 53years, %
Recently felt ill 46.4 37.5 34.2 30.9 36.0 0.016
Diabetes 8.0 6.5 4.0 1.5 1.7 ,0.001
Had cancer in the past 10y 4.0 4.2 2.4 2.0 3.6 0.1316
Thyroid disorders in the past 10y 6.4 4.2 5.4 2.6 4.7 0.148
Liver disease in the past 10y 2.4 2.4 0.6 0.2 1.1 0.029
Had recent major surgery 3.2 0.6 0.2 0.9 0.6 0.013
Weight (Kg) at 43y, mean (sd) 81.4 (16.9) 74.6 (14.6) 71.0 (12.9) 70.6 (12.6) 72.6 (13.6) ,0.001
Weight (Kg) at 53y, mean (sd) 71.1 (15.4) 71.3 (14.6) 71.4 (12.8) 74.2 (12.6) 82.8 (15.0) ,0.001
BMI (Kg/m2) at 43y, mean (sd) 29.0 (6.2) 26.0 (4.4) 24.9 (3.7) 24.6 (3.5) 25.5 (4.1) ,0.001
BMI (Kg/m2) at 53y, mean (sd) 25.5 (5.6) 25.2 (4.6) 25.3 (3.8) 26.1 (3.5) 29.4 (4.8) ,0.001
P values for the difference across weight change categories calculated with ANOVA (for continuous variables) and x2 tests (for categorical variables).
doi:10.1371/journal.pone.0086282.t001
Weight Loss and Mortality
PLOS ONE | www.plosone.org 3 January 2014 | Volume 9 | Issue 1 | e86282
conducted the statistical analyses using STATA software, version
12.0 (STATA Corp. – College Station, Texas).
Results
Similar percentages of men and women experienced weight loss,
and 11% lost more than 2 kg and 48% gained more than 5 kg
between 43 and 53 years. Participants grouped by weight change
categories differed across a number of factors (table 1). For
instance, there were greater percentages of men, those in lower
social classes, smokers and physically inactive in the groups who
lost weight compared with others. Weight gainers were lighter at
43 years than those who lost weight but heavier at 53 years.
Cardio-vascular disease at 43 years (angina, stroke and hyperten-
sion) and prevalent diseases at 53 years were uncommon and there
was little difference across groups, though lung function was lower
in those who lost compared to those who gained weight (table 1).
Weight Change and Mortality
The analysis using spline models suggested that the association
between weight change and mortality rates was not linear
(figure 1). There was increasing hazard of mortality with
increasing weight loss, but no increase for weight gain. Mortality
risks by weight change categories are reported in table 2, the
highest weight loss group has a particularly high rate compared
with all other groups. In unadjusted models, compared to modest
weight gain (2 to 5 kg), highest weight loss (25 kg or more) in
midlife was associated with up to nearly a four folds increase in
mortality rate up until 65 years in both the full and complete-case
sample. Adjustment for weight at 43 years and sex (model 2)
slightly attenuated this estimate, with further attenuation after
adjustment for physical activity level at 43 and 53 years, education
and SEP (model 3). The HR for the greatest weight loss group was
reduced further and was no longer significant when also adjusted
for cardio-vascular disease at 43 years and health status at
53 years (model 4).
In sensitivity analyses, when participants who lost more than
15 kg were excluded (n= 20), the HR for the highest weight loss
category (25 to ,215 Kg) compared with the reference group
was only modestly attenuated in a model adjusted for sex and body
weight at age 43 years (HR=2.5; 95% CI: 1.3, 5.0) when
compared with the main analysis. Similarly, when early deaths
(before age 55 years) (n = 12) were excluded, the HR for the high
weight loss group was significant through to model 3 (HR=1.8;
95% CI 1.0, 3.4). Also consistent with the main analysis, the HR
Figure 1. Weight Change (kg) Between 43 and 53 Years and all-
Cause Mortality Hazard Ratios (HRs) Between 53 and 65 Years
(95% CI bands, dotted lines), in the 1946 British Birth Cohort
(n =2 568; deaths = 141). HRs are from Fully Adjusted* Cox
Regression Using Cubic Splines and Median Weight Change
( = 4.8 Kg) as Reference Point.
doi:10.1371/journal.pone.0086282.g001
Table 2. Association between 10-year (43 to 53 years) weight change categories and all-cause premature mortality (53 to
65 years) in the 1946 British birth cohort.
N
No. of
Deaths1 Follow-up2 Rates3
Full
Sample1 Reduced sample4
Weight
change
Model 1 Model 2 Model 3 Model 4
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
25 kg or
more
141 22 1543 14.3 3.8 (2.1, 6.7) 3.8 (2.0, 7.0) 3.3 (1.7, 6.2) 2.8 (1.4, 5.3) 1.8 (0.9, 3.5)
25 to
22 kg
179 13 2013 6.5 1.7 (0.9, 3.3) 1.8 (0.9, 3.6) 1.7 (0.8, 3.4) 1.5 (0.7, 3.1) 1.2 (0.6, 2.5)
22 to
+2 kg
534 36 6173 5.8 1.6 (0.9, 2.6) 1.6 (0.9, 2.7) 1.6 (0.9, 2.8) 1.5 (0.9, 2.6) 1.3 (0.8, 2.3)
2 to 5 kg 570 25 6657 3.8 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference) 1 (Reference)
+5 kg or
more
1,326 68 15408 4.4 1.2 (0.7, 1.9) 1.2 (0.7, 2.0) 1.2 (0.7, 2.0) 1.2 (0.7, 1.9) 1.2 (0.7, 2.0)
Abbreviations: CI, confidence intervals; HR, hazard ratio;
1Based on the sample of participants with available data for mortality and weight change (n = 2 750; deaths = 164).
2Follow-up in person-years.
3Mortality rates are percentages per 1,000 person-years.
4Sample of participants with available data for mortality, weight change and all covariates through model 4 (n = 2 568; deaths = 144).
Model 1– unadjusted.
Model 2– adjusted for weight at age 43 years and sex.
Model 3– as in model 2 plus: educational attainment, socio-economic position, exercise level at 43 and at 53 years.
Model 4– as in model 3 plus: cardio-vascular disease and risk factors at 43y (angina, stroke, lung function (FEV1), hypertension), health conditions at 53y (cancer and
diabetes history, thyroid and liver disorders, recent major surgery or illness) and smoking habits at 43 and 53y.
doi:10.1371/journal.pone.0086282.t002
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was considerably attenuated and not significant in the fully
adjusted model (HR=1.4; 95% CI 0.7, 2.7).
In stratified analyses, the increased mortality rate in the highest
weight loss group (compared to the reference) was stronger and
remained significant after full adjustment (model 4) in non-smokers
(HR=2.9; 95% CI: 1.00, 6.7) but not in smokers at age 43 years
(HR=1.42; 95% CI: 0.5, 3.8) (p value for smoking by weight
change interaction in model 4 = 0.09). There was no evidence of
an interaction between weight change and obesity status
(BMI.30 kg/m2) at 43 years (p = 0.50). Finally, we found that
participants who were obese at 43 years (n = 334; 12% of the study
sample) had a higher mortality risk (HR=1.7; 95% CI: 1.1, 2.7)
compared to those who were in the normal weight category
(18.5,BMI,25; n= 1 421) at the same age. This association was
independent of their weight change between 43 and 53 years and
was hardly attenuated by adjustment for all other covariates.
Conversely, those who were obese at 53 years (n = 666; 24% of the
study sample) did not have a significantly higher mortality risk
(HR=1.4; 95% CI: 0.9, 2.7) compared to those who were normal
weight (n = 902) in similar models.
Discussion
In this prospective birth cohort study we found that compared
to modest weight gain (less than 5kg), weight loss of more than
5 kg in mid-life was associated with a higher risk of mortality
before old age (i.e., 65 years). The association was strongly
attenuated when cardiovascular risk factors and health status were
taken into account.
The obesity epidemic is spreading worldwide [20] and its link
with morbidity and mortality is well documented [21,22]. A few
years ago, Sorensen suggested that the fact that mortality is
increased by weight loss is a ‘painful paradox’ that clinicians may
regard with disbelief and some researchers have ascribed to the
fallacies of observational studies [12]. Our findings are in
agreement with previous research and suggest that smoking, and
underlying diseases that precede or coexist with weight loss may
confound the association with mortality [17]. Interestingly, our
results were unaltered when we conducted sensitivity analyses
excluding highest weight loss or early deaths intended to address
potential confounding due to pre-existing disease as others have
done [23]. Furthermore, our stratified analyses by smoking status
showed that in smokers the relationship between weight loss and
mortality was more largely accounted for by ill health, than in
non-smokers. A possible explanation is that health is poorer in
smokers compared to non-smokers, and initial symptoms and
clinical signs of disease may be milder in the latter, and thus they
might have been less captured by our health measures.
Our finding that health state strongly attenuates the association
between weight loss of more than 5kg and mortality is consistent
with a previous study also conducted in a UK population-based
sample [24]. However, weight loss remained significantly associ-
ated with higher mortality risk in studies that excluded from
analysis participants with poor health at baseline [25]. Both
positive [26–28] and null [24,29] associations have been reported
between weight loss and mortality. Discrepant results may be in
part explained by age differences at both baseline and follow-up
among studies, by cohort effects in mortality risk, [22] or how
health status was measured and accounted for in the analyses [17].
Unlike previous studies that were typically conducted in the
elderly, we focused on midlife weight change and premature death
(i.e. ,65) [12,23]. To our knowledge this is the first study to do
this and to show an association of this early weight loss with
mortality [10,30]. In addition, traditional methods of accounting
for ‘reverse causality’, like removing early deaths and controlling
for smoking, did not account for the effect of weight change on
mortality risk, different from health characteristics, which should
be accounted for in future studies.
Strengths and limitations
Our study has limitations. Mortality risks were higher amongst
those who were not compared to those who were included in our
analysis [31]. However, our analytic sample (n = 2 568) comprised
84% of those who took part in the 1989 resurvey (baseline of the
weight loss period). Moreover, response rates in the available
sample in 1989 and 1999 were high (80% or more) and the NSHD
study sample broadly maintained its nationwide representativeness
through the follow-up in 1999 [32]. We focused on premature
mortality, a small (albeit important) segment of total mortality and
indeed the total number of deaths was small (n = 164). Conse-
quently, causes of deaths could not be considered because of low
statistical power, and some estimates in the current analyses were
imprecise. We were not able to distinguish between intentional
and unintentional weight loss. However, if those who intentionally
lost weight in our sample did so to improve their health they might
have lowered their mortality risk hence shifting our findings
towards the null [6]. The beneficial effect on health of weight loss
in overweight and obese subjects is plausibly due to loss of fat mass,
[33] that we were unable to distinguish between fat and lean mass
loss is therefore another limitation of our study. Comparisons were
not made with those who maintained their weight in midlife (i.e.
22 to 2 kg category), who might be assumed to have lowest
mortality risks, but with those who gained between 2 and 5 kg.
However, the 2 to 5 kg weight change group and (accordingly) the
median weight change (+4.8 Kg) as referents in our analyses were
chosen consistently with studies that reported lowest mortality risks
in moderate weight gainers [34]. Strengths of the study include the
birth cohort design, the sample representativeness and the
available data on cardio-vascular disease and risk factors before
weight change and health characteristics after weight change
occurred; the latter being unlikely to improve with, or result from,
previous weight change (cancer, diabetes, thyroid and liver
disorders and major surgery). Finally, we carried out sensitivity
analyses to assess whether results were influenced by reverse-
causality, and stratified by obesity and smoking status to assess
possible effect modification.
Overall our findings may reflect illness-related weight loss, [9]
and also the aggravating effects of weight loss on the vital
prognosis of those with certain medical conditions [16]. This is
somewhat consistent with the conclusions of a recent systematic
review that questioned the health benefits of weight loss [10].
Indeed, weight loss is currently not recommended in geriatric
patients, [1] and the media have alluded that ‘chubby may be the
new healthy’ [35].
Conclusions
In the present study the direct association between weight loss
and risk of premature death was largely explained by modifiable
risk factors before and treatable clinical conditions after weight loss
occurred, and was independent of obesity at 43 years. Together
this may suggest that weight loss in midlife as well as obesity
warrants monitoring to improve prevention and tailor treatment.
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